|
Re: Revised target market, indications, market potential? ... and some numbers?
|
6
|
Resverlogix Corp.
|
Jun 14, 2020 02:25AM
|
|
Re: Revised target market, indications, market potential? ... and some numbers?
|
3
|
Resverlogix Corp.
|
Jun 13, 2020 11:27AM
|
|
Re: Revised target market, indications, market potential? ... and some numbers?
|
7
|
Resverlogix Corp.
|
Jun 13, 2020 09:55AM
|
|
Re: Presentation available
|
1
|
Resverlogix Corp.
|
Jun 10, 2020 12:38PM
|
|
Re: Presentation available
|
|
Resverlogix Corp.
|
Jun 10, 2020 12:22PM
|
|
Re: Presentation available
|
1
|
Resverlogix Corp.
|
Jun 10, 2020 12:17PM
|
|
Re: Price trickly upwards...
|
5
|
Resverlogix Corp.
|
Jun 10, 2020 10:27AM
|
|
Re: Presentation is over
|
3
|
Resverlogix Corp.
|
Jun 09, 2020 09:56AM
|
|
Re: Resverlogix Announces Corporate Update Conference Call & Webcast on June 10, 2020 and Upcoming Presentation at the 57th ERA-EDTA Virtual Congress on
|
7
|
Resverlogix Corp.
|
Jun 06, 2020 06:41PM
|
|
Re: Finance
|
2
|
Resverlogix Corp.
|
May 25, 2020 02:48PM
|
|
Re: Address your Shareholders Donald J. McCaffrey
|
5
|
Resverlogix Corp.
|
May 14, 2020 09:53AM
|
|
Re: Todays trading
|
9
|
Resverlogix Corp.
|
Apr 30, 2020 04:54PM
|
|
Re: Why wouldn't our CEO Donald McCaffrey address his shareholders during these troubling times?
|
3
|
Resverlogix Corp.
|
Apr 27, 2020 07:24PM
|
|
Re: Why wouldn't our CEO Donald McCaffrey address his shareholders during these troubling times?
|
12
|
Resverlogix Corp.
|
Apr 27, 2020 04:56PM
|
|
Re: the happening/not happening scale
|
8
|
Resverlogix Corp.
|
Apr 09, 2020 10:20PM
|
|
Re: In Fierce Biotech this morning
|
4
|
Resverlogix Corp.
|
Apr 09, 2020 01:04PM
|
|
Subsequent Study/Trial
|
6
|
Resverlogix Corp.
|
Apr 03, 2020 06:54AM
|
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
14
|
Resverlogix Corp.
|
Apr 01, 2020 07:02PM
|
|
Re: Finance
|
3
|
Resverlogix Corp.
|
Mar 29, 2020 06:06PM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
4
|
Resverlogix Corp.
|
Mar 27, 2020 02:11PM
|
